Loading...
Loading...
Shares of Arena Pharmaceuticals, Inc
ARNA are lower on the session by 7.5%, currently trading at $2.52
Options volatility is bid with the April volatility +6.1 points and the May vol +7.4 points.
An FDA Adcom vote is scheduled for May 10th.
Arena is a biotech company specializing the the weight-loss market.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in